Roche Among EU Fast-Track Hopefuls With Lymphoma Bispecific Mosunetuzumab

 
• By Neena Brizmohun
The EMA can review marketing applications faster under its accelerated assessment mechanism • Source: Alamy

More from Europe

More from Geography